Project Partners

unibo logo
Alma Mater Studiorum - Università di Bologna (UNIBO)

The University of Bologna, founded in 1088, values the unique potential of each individual, focusing on openness and the opportunity to express every talent. It believes in contributing to the common good and the importance of co-creating value with the community and society. With a millenary history, the Alma Mater strives for educational and scientific excellence, promoting broad relationships at the local and international levels. The academic community, composed of teaching staff, administrative staff, and students, is committed daily to addressing future challenges, valuing diversity, and promoting inclusion and equity. Its innovative teaching approach and focus on innovation aim to meet society's needs by exploring new educational methodologies to provide current and future skills.

Role in the DARE Project

UNIBO leads the DARE project, coordinating Spoke 1 on the legal, ethical, and data security framework, and co-leading Spoke 2 on primary prevention. It is responsible for technological development and training activities aimed at strengthening digital prevention skills. It contributes to the Salus Ratio platform for the analysis of sensitive data, HPC infrastructures, and laboratories specialised in diagnosing frailty and developing wearable technologies. Additionally, it brings expertise in health and lifestyles data analysis and monitoring, including the use of motor control data from developing subjects.

Università degli Studi di Palermo (UNIPA)

The University of Palermo, founded in 1806, with its over 40,000 students, is one of the 11 mega universities in Italy. In recent years, the University of Palermo has increasingly dedicated its energy to its Third Mission, enhancing and transferring knowledge for the benefit of the territory.

Role in the DARE Project

Within the DARE initiative, UNIPA coordinates the activities of Spoke 2, focused on digital primary prevention. An advanced and interoperable surveillance system will be developed, powered by an innovative digital infrastructure that integrates administrative, health, environmental, and climate data. This system aims to provide risk assessments and targeted interventions based on lifestyle, health determinants, environmental pollution, and genomic profiling, both in daily life and work environments. Innovative community-based digital primary prevention interventions will also be implemented, particularly focusing on cancer, cardiovascular diseases, developmental disorders, and communicable diseases. UNIPA will establish the first Regional Research Center for Digital Prevention in Italy, offering technical and scientific support to local health and environmental authorities. UNIPA will also provide advanced training in the biomedical, bioinformatics, and health sectors through undergraduate courses, master's programs, advanced postgraduate courses, and training programs.
Uniroma2
Università degli Studi di Roma Tor Vergata (UNIROMA2)

The University of Rome "Tor Vergata" began its teaching activities in 1982. Designed on the model of Anglo-Saxon campuses, it occupies an area of about 600 hectares. This particular extension has allowed the development of each of the six Macroareas in separate structures, built in large dedicated spaces: Economics, Law, Engineering, Humanities and Philosophy, Medicine and Surgery, Mathematical, Physical and Natural Sciences.

Role in the DARE Project

The University participates in research in Spoke 1 and Spoke 3. In Spoke 1, researchers in Economics, Finance, and Computer Science will develop a harmonised data platform to analyse the effect of digital technologies on health, informing decisions on new technologies in Spoke 3. Together with the Departments of Electronics and Chemistry, they will focus on wearable and implantable sensors, human-computer interfaces, and assistive robotics.

As the leader of Spoke 3, the focus is on digital personalisation in medicine, tools for screening and early diagnosis, the discovery of digital biomarkers, and the continuity of preventive care. This activity is supported by the Department of Industrial Engineering for the development of personalised medicine methods based on AI, utilising machine learning from clinical datasets.

aou bo logo
AOSP IRCCS S.Orsola Bologna (IRCCS AOU BO)

The IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant’Orsola is a very old hospital (the first nucleus dates back to 1592) and is home to the Faculty of Medicine and Surgery of the University of Bologna. With 1,076 researchers (including doctors, biologists, technicians, and healthcare professionals, 212 professional research collaborators, 1,897 publications in national and international specialized journals, and over 2,345 active clinical studies), the Policlinico di Sant’Orsola is also a Scientific Institute for Research, Hospitalization, and Healthcare in two research areas in which Bologna is already a reference point at a national and international level: transplantation and critical patient care, and the integrated medical and surgical management of oncological diseases.

Role in the DARE Project

 The IRCCS AOU BO is involved in Spokes 2 and 3 of DARE, participating in 6 pilot studies on clinical AI, telemedicine, and solid organ transplants (SOT). The IRCCS AOU BO will focus on:
  • Developing AI tools to monitor diseases and optimise hospital management;
  • Preventive strategies and care pathways for patients with Down syndrome;
  • Improving surveillance and risk stratification for diseases such as colorectal cancer;
  • Using telemedicine for family-centered care pathways;
  • Optimising clinical pathways and alert systems for IBD;
  • Researching biomarkers to improve solid organ transplants.
 
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (FPG)

The mission of the Foundation, as a Catholic-inspired University Hospital, is to offer patients humanity, excellence and high specialisation in care, promoting constant innovation in medicine and training the health professionals of the future. The Foundation is the place where scientific and technical skills, human sensitivity, ethics and Catholic values become a concrete commitment to the service of all for excellent and accessible care for the whole community. The Gemelli Polyclinic and the Faculty of Medicine are positioned at the heart of the health system, developing and disseminating a national and international reference model for the management, organisation, technology and humanisation of medicine.

Role in the DARE Project

FPG is involved in spokes 2 and 3, having the essential equipment for molecular biology, but with the need for new investments for ambitious results. It established the Gemelli Science and Technology Park (G-STeP) to coordinate research in life sciences, offering certified services to researchers and companies. G-STeP facilities include: Biobanking, Bioinformatics, Data Collection, Epidemiology-Biostatistics, Flow Cytometry, Genomics, Metabolomics, Microbial Analysis, Microscopy, Proteomics and Real-World Data. Support also comes from the Clinical Governance Unit for the management of critical pathways.
Azienda Unità Sanitaria Locale della Romagna (AUSL ROMAGNA)
The Local Health Unit of Romagna, established by Regional Law no. 22 of 21 November 2013, is the instrumental body through which the Region ensures the essential and uniform levels of assistance in the territorial area of Romagna. The Company has public legal personality and entrepreneurial autonomy in accordance with the national and regional legislative provisions regulating the Health Service. The Company aims to promote, maintain and improve the health, both individual and collective, of the resident population and in any case present in any capacity in its territory, to allow the best possible quality of life, guaranteeing the essential levels of assistance, as required by national and regional legislation.

Role in the DARE Project

The Local Health Authority (AUSL) of Romagna undertakes the coordination of the interventions of the project through the Department of Internal Medicine, collaborating as an affiliate to spokes 1 and 2. For Spoke 1, it contributes to Work Package 5 (WP5), while for Spoke 2, it contributes to Work Package 4 (WP4).
asl ba
Azienda sanitaria locale della provincia di Bari (ASL BARI)

The ASL of Bari, established in 2006 from the merger of four ASLs in the former Province of Bari, operates with entrepreneurial autonomy. It serves the area through 12 Socio-Health Districts, 5 directly managed hospitals, a classified hospital “Ente Ecclesiastico Ospedale Generale Regionale Miulli” and the IRCCS “Salvatore Maugeri” in Cassano delle Murge, in addition to accredited private facilities. It offers "essential levels of care" ("LEA") services that include basic healthcare, pharmaceutical, outpatient specialist, residential, semi-residential, and continuous care services, including the management of the COVID-19 emergency through the U.S.C.A. 

Role in the DARE Project

ASL BARI coordinates the project's interventions through the Department of Territorial Assistance and the Department of Prevention, collaborating in Spokes 1 and 3. It will contribute to WP5 in Spoke 1 for impact analysis and policy making, and in Spoke 3 to WP3 and WP5, focusing on digital tools for cancer screening and early diagnosis, and on the integration of digital technologies and digital therapies to improve care for patients with chronic kidney disease and other chronic non-communicable diseases.
aoup logo
Azienda Ospedale Università Padova (AOUP)

The Padua Hospital-University (AOUP), established in 1994, is a national reference hospital with high specialisation, integrated with the University of Padua to provide healthcare services, education, and research. Its mission is to harmonise medical care with education and scientific innovation, contributing to the goals of the Regional Health Service and the university. AOUP aspires to be a nationally and internationally recognised centre of excellence by promoting high-quality education, improving healthcare services, and advancing research. mira inoltre It also aims to be a reference point for the integration of healthcare, education, and research, while strengthening its presence in the global healthcare and scientific network. The AOUP seeks to attract patients and professionals from around the world, solidifying its role as a hub for advanced medical services, high-quality training, and cutting-edge research. 

Role in the DARE Project

The Azienda Ospedale-Università di Padova (AOUP) IS affiliated with spoke 3. AOUP provides the following data:
  • Hospital Data relating to approximately 40,000 annual admissions.
  • Laboratory and microbiology data, with around 1 million tests conducted.
  • Data from the emergency department, including around 100,000 annual visits.
Azienda sanitaria locale Roma1 (ROMA1)

The Local Health Authority is the reference point for the health needs of residents in the Roman territory. ASL Roma 1 includes three directly managed hospitals: San Filippo Neri Hospital, Santo Spirito Hospital, and the Mono-specialistic Ophthalmic Hospital - a regional reference centre. Day hospitalisation activities are also available at the S. Anna Women's Health Centre and the Sant'Andrea facility on Via Cassia. Additionally, the Nuovo Regina Margherita facility is integrated with Santo Spirito Hospital for specific medical and surgical care pathways. 

Role in the DARE Project

ROMA1 plays an active role in the project within Spoke 2, the Community-Based Integrated Advanced Surveillance System (ACISS). Additionally, it participates as an implementing entity in Work Packages 1 and 4, which include, among other activities, predictive models for automatic disease surveillance systems (UNIBO) and the use of digital technologies to support vaccination programs (FPG+ASL Roma 1). ROMA1 provides the project with its Primary Health Care facilities: community health centres, outpatient clinics, and vaccination hubs.
ptv logo
Fondazione Policlinico Tor Vergata (PTV)

The PTV Foundation, in line with the reformulation of its Statute, acts as a reference body for managing healthcare activities, research (experimental, clinical, and technological), and education. It integrates these areas with patient care to enhance the educational potential of the University. Its mission is to ensure high-quality healthcare, promote excellence in medical and health education, and strengthen biomedical and clinical research. The Foundation emphasises human-centred care and strives to improve healthcare protocols and organisational innovation, creating a service-oriented hospital focused on the individual. 

Role in the DARE Project

PTV collaborates with UNIROMA2 in pilot projects within Spoke 3, specifically supporting the following tasks:
  • Cardiovascular radiomics for risk stratification of post-operative adverse events.
  • Digital tools for children and vulnerable elderly populations.
  • Digital tools in cardiometabolic diseases.
  • Introduction of medical digitalization within the Italian Solid Organ Transplant Network.
  • Optimization of therapy and prevention of adverse events in diabetes management.
  • Prevention/mitigation of frailty within the continuum of care.
bellaria
AUSL BO - IRCCS Istituto delle Science Neurologiche di Bologna (IRCCS ISNB)

The ISNB is an IRCCS focused on clinical and translational research in neurology, specialising in neurodegenerative diseases, movement disorders, neuromuscular disorders, sleep disorders, and epilepsy, as well as neurosurgery and neuroradiology. Born from the merger of the neurological structures of the Azienda USL of Bologna and the University Neurological Clinic, it is located at Bellaria Hospital and extends across the metropolitan area of Bologna. It manages the HUB for neurological vascular emergencies, rehabilitation of brain injuries, and coordinates adult neurological activities. It is a reference centre for epilepsy surgery, pituitary and paediatric neurosurgery and plays a key role in university teaching and continuous education in the field of neuroscience. 

Role in the DARE Project

The Institute participates in Spoke 3 – WP4 of the project, leveraging advanced infrastructures for cellular and molecular biology. It has platforms for next-generation sequencing, capillary electrophoresis sequencing, multiplex and ultra-sensitive protein analysis technologies, mass spectrometry, and a 3T MRI scanner with a 64-channel coil. 

logo birex
BI-REX Competence Centre - Big Data Innovation & Research Excellence (BI-REX)

BI-REX (Big Data Innovation and Research Excellence) is one of the 8 National Competence Centres established by the Ministry of Enterprises and Made in Italy (formerly MISE) as part of the government’s Industry 4.0 plan. Our public-private consortium, founded in 2018 and based in Bologna, brings together 60 partners including universities, research centres, and leading companies, with a specialised focus on Big Data. BI-REX is the only Competence Centre led by industry. 

Role in the DARE Project

BI-REX, a founding partner of the HUB and affiliated with Spokes 1, 2, and 3, is the Leader of WP7 in Spokes 2 and 3, handling technology transfer, valorisation of research results, dissemination, and startup acceleration. It offers technological demonstrations and practical training support on I4.0 technologies in its Pilot Plant, an intelligent factory. BI-REX also promotes public engagement through matchmaking events, investor meetings, and webinars. Through CINECA and INFN, it will provide access to HPC infrastructures for data analysis, supporting research, development, and innovation in Spoke 1.
logo gimbe
Fondazione Gimbe (GIMBE)
The GIMBE Foundation is an independent non-profit organisation that, for over 25 years, has worked through research, education, and advocacy to protect citizens' rights, reduce inequalities and waste, and promote the sustainability of a public, equitable, and universal healthcare system. In March 2013, GIMBE launched the #salviamoSSN campaign and since 2016 has published the "National Health Service Report" to raise awareness about the importance of preserving public healthcare for future generations. The GIMBE Observatory continuously monitors stakeholder actions to ensure efficient use of public health funds.

Role in the DARE Project

The GIMBE Foundation participates in Spokes 1 and 2. In Spoke 1, it produces evidence-based reports on the effectiveness of preventive interventions and ensure the widespread dissemination of DARE's results among healthcare professionals, patients, and the public through scientific publications, events, websites, social media, and newsletters. In Spoke 2, GIMBE focuses on education and training, developing programs for healthcare professionals and offering training activities for professionals and the public. Based in Bologna, GIMBE has a strong IT infrastructure and an extensive national and international network of healthcare stakeholders.

aoupct
Azienda Ospedaliero Universitaria di Catania (AOUPCT)
The Azienda Ospedaliero Universitaria Policlinico "G. Rodolico – San Marco" in Catania plays a significant role in the Sicilian Health System (SSR), offering advanced healthcare and serving as a regional hub. In collaboration with the University of Catania and the Sicilian Biomedical District, the institution focuses on research, innovation, and the development of advanced therapies and diagnostic technologies. The hospital integrates healthcare with academic and research goals, promoting quality care, education, and management experimentation while advancing translational medicine and new technologies.

Role in the DARE Project

The RTI CT-ME-EN network is dedicated to oncological surveillance and occupational risks, with a focus on clinical governance and research. Key objectives include monitoring cancer, studying its causes, planning and assessing preventive interventions, improving access to care, and optimizing healthcare costs. Contributing to Spoke 2, AOUPCT supports the development of a digital infrastructure for an advanced cancer surveillance system. This system integrates epidemiological, environmental, occupational, clinical, and biomolecular data for detailed studies and the evaluation of preventive measures. The AOUPCT supports the development of a digital infrastructure for an advanced cancer surveillance system, combining epidemiological, environmental, labour, clinical and biomolecular data for detailed studies and evaluation of the effectiveness of preventive measures.

logo eng
Engineering S.P.A. (ENG)
Engineering is a Digital Transformation Company, a leader in Italy and continually expanding worldwide, with around 15,000 employees and over 70 offices. 
The Engineering Group, consisting of over 70 companies in 21 countries, has been supporting the continuous evolution of companies and organisations for more than 40 years, thanks to a deep understanding of business processes in all market segments, fully leveraging the opportunities offered by advanced digital technologies and proprietary solutions. 
It integrates best-of-breed market solutions, managed services, and continues to expand its expertise through M&As and partnerships with leading technology players. The Group strongly invests both in innovation, through its R&I division, and in human capital, with the internal IT & Management Academy. Engineering is a key player in the creation of digital ecosystems that bridge the gap between different markets, while developing composable solutions that ultimately foster a continuous Business transformation.

Role in the DARE Project

ENG, as an affiliated partner in Spokes 1 and 2, focuses on research to support disease prevention through decision support tools for Population Health Management. These tools aim to assist the decision-making processes of healthcare professionals and policymakers by providing automated recommendations and useful information based on guidelines, standards, and knowledge derived from machine learning techniques. ENG applies these research areas to enhance the knowledge of healthcare professionals and patients in the primary prevention diseases, e.g.: chronic metabolic, cardiac, oncological, and neurodegenerative, utilizing proprietary products such as Ellipse, previous developments, and the Unified Health Model (UHM) to integrate demographic, clinical, and other relevant data.

EXPRIVIA logo
Exprivia S.P.A.
Exprivia is an international group specialised in Information and Communication Technology, with a consolidated know-how and long experience gained from its constant presence in the market. The group has a team of experts specialised in various technological fields and supports its clients in the sectors of Healthcare, FinTech, Telco & Media, Energy & Utilities, Aerospace & Defence, Manufacturing, and the Public Sector.
In the healthcare sector, Exprivia is present throughout the national territory with solutions for diagnostic imaging (RIS-PACS), clinical (electronic health records, telemedicine), emergency room, reception and booking, electronic prescribing, and essentially every IT solution aimed at system interoperability and regional collaboration.
EXP stands out for significant investments in national and European R&D projects and Innovation programs through Open Innovation, merger & acquisition, technological partnerships, and the enhancement of R&D&I ecosystems (districts, associations, consortia, technological partnerships).

Role in the DARE Project

Exprivia, a founding member of the Hub and affiliated with Spokes 1 and 3, specialises in the creation of digital solutions for a healthcare system capable of combining savings, effectiveness, and efficiency. Therefore, in DARE, it provides its know-how, proprietary technologies, and products primarily to: (i) develop AI-based models aimed at addressing demand, prescription appropriateness, and the correct use of hospital resources, particularly in the emergency and inpatient settings; (ii) improve the collection and use of multidimensional data on a regional scale, using its own storage systems and clinical decision systems; (iii) support the collaboration of initiatives with regional and national systems.

logo infn
Istituto Nazionale di Fisica Nucleare (INFN)

The INFN is the national public research institution, overseen by the Ministry of Education, Universities, and Research (MIUR), dedicated to the study of the fundamental constituents of matter and the laws that govern them. It conducts theoretical and experimental research in the fields of subnuclear, nuclear, and astroparticle physics. INFN's research activities take place within an international competitive framework and in close collaboration with the Italian university system, based on well-established and decades-long relationships. Fundamental research in these sectors requires the use of cutting-edge technologies and research tools that INFN develops both in its own laboratories and in collaboration with the industrial sector. INFN was established on August 8, 1951, by groups from the Universities of Rome, Padua, Turin, and Milan to continue and develop the scientific tradition started in the 1930s with the theoretical and experimental nuclear physics research of Enrico Fermi and his school.

Role in the DARE Project

INFN manages the largest computing infrastructure in Italy, with one national centre and nine medium-sized centres, connected by 100 Gbit/s networks managed by GARR. It focuses on advanced Cloud services, based on open-source, for computing, storage, HPC, and big data analysis needs, including sensitive data, ensuring security through ISO-certified centres. INFN's expertise in handling sensitive big data will be employed in Spoke 1 of the project, leading WP3 and contributing to WP2, WP4, and WP6.

ior
Istituto Ortopedico Rizzoli (IOR)

The Rizzoli Orthopaedic Institute (IOR) is a highly specialised hospital for assistance and research in the field of orthopaedics and traumatology. In 1981, the Ministry of Health declared Rizzoli an Institute for Treatment and Research of a Scientific Nature (IRCCS), recognising the high level of healthcare and research achieved by the institute in the orthopedic and traumatological field.

Role in the DARE Project

IOR plays a key role in Spokes 1, 2, and 3 of the project:
In Spoke 1, it contributes to the identification and development of technologies, handling data extraction and management, development of services for interoperability, and integration of models.
In Spoke 2, it develops digital tools for primary prevention, including assessing the propensity for falls in the elderly based on the evaluation of the ageing neuromuscular control.
In Spoke 3, it offers digital products for secondary and tertiary prevention, such as digital models of the human body and the search for digital biomarkers for musculoskeletal diseases through imaging diagnostics and movement analysis.
Istituto Tumori Bari Giovanni Paolo II IRCCS (IRCCS BARI)

The Istituto Tumori is a public law research institute specialised in oncology, confirmed by ministerial decree in 2014. Originating from the Cancer Centre of 1933, it became a specialised Oncology Hospital in 1976 and was recognised as an IRCCS in 1985. Located in the former "DOMENICO COTUGNO" Hospital in Bari, the Institute is committed to oncological research and assistance, following national and regional health objectives. It is recognised as a centre of excellence for pre-clinical, translational, and clinical research, as well as for care, having obtained international accreditation as a Clinical Cancer Centre from the Organisation of European Cancer Institutes (OECI) in 2015, adhering to international standards of multi-disciplinarity, innovation, and quality care. 

Role in the DARE Project

In Spoke 3, IRCCS GPII BA collaborates with Prof. Luisa Torsi in the development of tests for the early diagnosis of lesions related to infections (WP4) and in the identification of specific signatures as predictive markers for cancer using digital tools (WP3). A multidisciplinary group led by Dr. Raffaella Massafra uses AI models, such as Convolutional Neural Networks, to analyse pathological images and automatically identify tumour characteristics or lymphocytic infiltrates, supporting more personalised patient management. The institute has all the necessary facilities, including molecular biology laboratories, a biobank, GMP laboratories, and bioinformatics laboratories, in addition to administrative offices supporting scientific activities.
mchgvm logo
Maria Cecilia Hospital - Gruppo Villa Maria S.P.A. (MCH GVM)

Maria Cecilia Hospital (MCHGVM), part of GVM Care & Research, an Italian private group engaged in healthcare, research, biomedical industry, thermal care, and business services, is one of the main centers for high specialty and complex diagnostic and interventional services in Emilia-Romagna and Italy, particularly in the treatment of cardiovascular diseases. MCHGVM is experiencing significant clinical and scientific development thanks to the integration of clinical activity with a significant contribution from basic, translational, and clinical research. The organisational structure dedicated to research is governed by the Scientific Directorate, which relies on various structured support services such as a translational research centre, a clinical trials unit, biostatistics and epidemiology, a grant office, the Cardiopers-Lab laboratory, and a scientific library.

Role in the DARE Project

MCHGVM contribuisce all’iniziativa negli spoke 2 e 3, mediante azioni in 3 work-package.

  • Spoke 2 (WP4): The DIPPER pilot is structured in two directions: one involves the implementation of a large-scale digitized prevention process for non-communicable diseases, providing evidence-based recommendations visible to each recruited individual on a dedicated web portal; the other involves the creation of personalized primary prevention programs supported by telemedicine systems for individuals with cardiovascular risk factors to reduce their risk and promote lifestyle changes.
  • Spoke 3 (WP2): Coronary Radiomics. The aim of the study, in collaboration with the University of Rome Tor Vergata, is to identify digital radiomic markers of the coronary arteries in a population with a previous cerebrovascular stroke event and in a control population.
  • Spoke 3 (WP4): The aim of the pilot study, in collaboration with the Rizzoli Orthopaedic Institute and Sant’Orsola Polyclinic, is to identify predisposing factors for ulcerative risk in the feet of patients with type 2 diabetes, using a multimodal and multi-instrumental approach that integrates clinical/metabolic, biological/biochemical, and biomechanical/functional data. MCHGVM will contribute to the definition of the risk score through the search for circulating inflammatory biomarkers. 
UCSC LOGO
Università Cattolica del Sacro Cuore (UCSC)

UCSC is an academic community that contributes to the development of studies, scientific research, and the preparation of young people for research, teaching, public and private offices, and free professions. UCSC fulfils these tasks through adequate higher education and education informed by the principles of Christianity, respecting the autonomy of every form of knowledge, and according to a conception of science that serves the human person and civil coexistence, in accordance with the principles of Catholic doctrine and in line with the universal nature of Catholicism and its high and specific demands for freedom as stated in Article 1 of the Statute.

Role in the DARE Project

UCSC contributes to Spokes 1 and 2. As part of the activities planned for Spoke 1, the Hygiene Section of the Department of Life Sciences and Public Health is primarily engaged in identifying relevant criteria for measuring the utility and implementability of digital preventive interventions, synthesizing the obtained evidence, and identifying and creating a network of stakeholders for the co-creation of personalized digital prevention strategies.

uke logo
Università degli Studi di Enna "Kore" (UKE)

The UKE, Kore University of Enna, is a legally recognized non-state university authorized to issue legally valid academic degrees, including Bachelor's degrees, Master's degrees, first and second-level Master's degrees, and Doctorates. The name Kore was preferred over Persephone, Proserpina, or Libera—all attributed to the same figure—because its widespread use connotes all Mediterranean civilizations, those further north and south, and those more western and eastern, thus better describing, compared to the other names of the same myth, the infinite directions of research and knowledge and the relationships between cultures.

Role in the DARE Project

In support of Spoke 1 activities, the Hygiene Section possesses multidisciplinary expertise in medicine, physics, biology, chemistry, public health, sanitary engineering, health management and economics, epidemiology and statistics, as well as in legislative, sociological, and ethical domains. Within the framework of Spoke 2 activities, the Department of Cardiovascular and Pulmonary Sciences brings the necessary experience to develop and implement prevention programs for cardiovascular diseases.

logo bari aldo moro
Università di Bari Aldo Moro (UNIBA)

The University of Bari "Aldo Moro," founded by Decree on October 9, 1924, has roots in the ancient University Schools of Pharmacy and Notary established after the Unification of Italy. It has grown significantly over time, adding the Faculties of Medicine and Surgery, Law, Economics and Commerce, Agriculture, and later Arts and Philosophy, Sciences, Engineering, Education, Veterinary Medicine, and Foreign Languages and Literatures. The University of Bari is also distinguished by its international activities and cultural cooperation agreements with universities worldwide, hosting the Consortium of Mediterranean Universities and being a founder of the Technopolis-CSATA Novus Ortus Scientific and Technological Park. In 2008, the university was named after Aldo Moro, solidifying its legacy of educational and research excellence.

Role in the DARE Project

The University of Bari is involved in the proposal as an affiliate of the first and third spokes. For the first spoke, UNIBA assumed the role of Co-Principal Investigator and lead WP7. Regarding the third spoke, UNIBA leads WP4. Concerning research infrastructures that can be made available for the initiative, UNIBA has established and manages, together with INFN, the ReCaS Data Centre, a computational infrastructure for HPC and cloud computing (10K CPUs, 15 PB of storage), designed to support large-scale data mining and machine learning model training. Additionally, UNIBA has recently established the Centre for Innovation in Single Molecule Digital Assay, which aims to develop technologies for molecular diagnostics through microsystems and medical devices or the creation of new high-tech platforms for early non-invasive diagnosis and personalised therapies.

unipd logo
Università degli Studi di Padova (UNIPD)

The University of Padua (UNIPD), founded in 1222, is among the oldest universities in the world and boasts a solid reputation for excellence in both research and teaching. Its 32 departments cover an exceptionally wide spectrum of research areas, including humanities, social sciences, engineering, physics, technology, life sciences, medicine, and natural sciences. UNIPD currently offers over 200 study programs (93 undergraduate programs, 100 master's programs, and 10 single-cycle degree programs) with approximately 68,000 total enrolled students. There are also 40 doctoral programs with a total of 1,800 students, an excellent school, and over 60 specialisation schools. UNIPD employs over 2,200 faculty members and over 2,400 technical and administrative staff and has long been positioned at the highest levels of international rankings for the quality of teaching, research, and services (in the 2024 global rank, it is ranked 219 by QS, in the 150-200 range by ARWU, and in the 201-250 range by THE).

Role in the DARE Project

UNIPD's participation in the DARE initiative involves seven departments, four in Spoke 2 (Department of Women's and Children's Health – SDB; Department of Developmental Psychology and Socialization – DPSS; Department of General Psychology – DPG; Department of Physics and Astronomy – DFA) and three in Spoke 3 (Department of Information Engineering – DEI; Department of Surgical, Oncological and Gastroenterological Sciences – DISCOG; and Department of Cardiac, Thoracic, Vascular Sciences and Public Health – DSCTV). All participating UNIPD departments in DARE possess cutting-edge research infrastructures both clinically and computationally, boast high-level scientific production, a demonstrated ability to attract both public and private funding, and have established national and international networks with public partners and enterprises. All seven departments are included in the MUR list of 350 departments eligible for the selection of "departments of excellence" (Art.1, Law 221/2016) for the five-year period 2023-2027.
unipr logo
Università degli Studi di Parma (UNIPR)

The University of Parma is a privileged place for higher education and the advancement of knowledge, aiming to contribute to the development of society through the cultural and civil promotion of individuals and the creation of a culture based on the universal values of human rights, peace, international solidarity, and environmental protection, as stated in the University's Statute. 

Role in the DARE Project

Researchers from DIMEC, experts in imaging diagnostics and clinical medicine, contribute to Spoke 3 by leveraging their experience in personalised medicine. They provide clinical data and access to advanced clinical tools. Researchers from DIA, with their technical expertise, support Spoke 1 and offer technical assistance to medical research groups in Spoke 3, promoting innovative approaches in technological research fields. Collaboration with law departments addresses the ethical and legal issues arising from AI, focusing on explainable AI (XAI) to mitigate ethical biases in AI applications. Additionally, UNIPR's research, particularly concerning computing needs, relies on a central high-performance computing (HPC) cluster developed with INFN, highlighting the commitment to enhancing research capabilities through high-performance computing, with a focus on efficiency and innovation in managing computing resources for scientific research.

logo arpa sic
AGENZIA REGIONALE PER LA PROTEZIONE DELL'AMBIENTE SICILIA (ARPA)

The Regional Agency for Environmental Protection (ARPA) Sicily, established by Regional Law 6/2001, operates under the supervision of the Regional Department of Territory and Environment of Sicily. ARPA's mission is to protect the environment through monitoring, control, and sustainable development. Its activities include technical assessments, environmental management, research, education, and ecosystem monitoring. The agency supports regional authorities, healthcare companies, and collaborates with local and national bodies to safeguard the environment, focusing on research initiatives and professional training in environmental matters. 

Role in the DARE Project

Arpa Sicilia contributes to Spoke 2 as part of the “Population-Based Digital Primary Prevention (PDPP)” project, where it provides environmental data related to the monitoring of air, water, soil, waterways, and water basins, as well as productive and industrial settlements, alongside physical pollutants such as radio frequencies and noise. It makes its laboratory and environmental monitoring equipment available to integrate environmental data with the project's application architectures. A new hardware infrastructure will need to be acquired and installed in its data centre to manage environmental data, ensuring compliance with national and EU regulations, such as GDPR, and adherence to industry best practices and project standards defined by the stakeholders of Spoke 1.

upmc logo
University of Pittsburgh Medical Center Italy SRL (UPMCI)

UPMC (University of Pittsburgh Medical Center) is one of the largest healthcare and insurance systems in the United States. It works closely with the University of Pittsburgh to develop models of healthcare and research excellence. Our facilities in Italy offer immediate access to specialised and advanced care. UPMC's mission is to contribute to the development of the healthcare system of tomorrow by promoting clinical innovation and developing new healthcare management models, thanks also to significant investments in research and training. We cultivate a new idea of patient-centred healthcare based on medical-scientific and technological innovation to inspire and promote a model of responsible, effective, and quality care. 

Role in the DARE Project

UPMC Italy participates in the activities of Spoke 2, specifically in Work Packages 1, 3, 4, 6, and 7.